nach oben

Breast Cancer Research and Treatment

Erschienen in:

05.06.2019 | Epidemiology

Is core needle biopsy effective at diagnosing male breast lesions?

verfasst von: Yinlong Yang, Shiping Li, Guangyu Liu, Zhiming Shao

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective of this study was to examine the diagnostic accuracy of sonographically guided core needle biopsy (CNB) of breast lesions in men.

Methods

This was a retrospective study where we analyzed consecutive sonographically guided 14-gauge CNB results on 234 male breast lesions. The CNB accuracy is determined by the comparison between the CNB and its corresponding excisional biopsy or to long-term follow-up imaging.

Results

Sonographically guided CNB was effective to collect satisfactory samples from all 234 lesions. Out of those, 58.55% (137/234) were benign, 38.0% (89/234) were malignant, 1.71% (4/234) were papilloma with atypia and 1.71% (4/234) were atypical ductal hyperplasia lesions. Underestimation occurred in 3.4% (8/234) of the lesions. As for the detection of breast malignancy, the sensitivity of the CNB is 98.9%, specificity is 100%, negative predictive value is 99.3%, positive predictive value is 100%, false positive is 0% and false negative is 1.1%. The overall accuracy of sonographically guided CNB as a diagnostic tool is 99.6%.

Conclusion

Sonographically guided 14-gauge CNB is an accurate, reliable and low invasive procedure for assessing breast lesions in men. Triple tests and follow-up checks of benign cases are essential for a successful breast biopsy program in men.

Giordano SH (2018) Breast cancer in men. N Engl J Med 378(24):2311–2320. https://doi.org/10.1056/NEJMra1707939 CrossRefPubMed

Agrawal A, Ayantunde AA, Rampaul R, Robertson JF (2007) Male breast cancer: a review of clinical management. Breast Cancer Res Treat 103(1):11–21. https://doi.org/10.1007/s10549-006-9356-z CrossRefPubMed

Giordano SH (2005) A review of the diagnosis and management of male breast cancer. Oncologist 10(7):471–479. https://doi.org/10.1634/theoncologist.10-7-471 CrossRefPubMed

Meattini I, Bicchierai G, Saieva C, De Benedetto D, Desideri I, Becherini C, Abdulcadir D, Vanzi E, Boeri C, Gabbrielli S, Lucci F, Sanchez L, Casella D, Bernini M, Orzalesi L, Vezzosi V, Greto D, Mangoni M, Bianchi S, Livi L, Nori J (2017) Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: single-institution experience and review of published literature. Eur J Surg Oncol 43(4):642–648. https://doi.org/10.1016/j.ejso.2016.10.025 CrossRefPubMed

Hoda RS, Arpin RN, Gottumukkala RV, Hughes KS, Ly A, Brachtel EF (2019) Diagnostic value of fine-needle aspiration in male breast lesions. Acta Cytol. https://doi.org/10.1159/000494486 CrossRefPubMed

Pailoor K, Fernandes H, Cs J, Marla NJ, Keshava SM (2014) Fine needle aspiration cytology of male breast lesions—a retrospective study over a six year period. J Clin Diagn Res 8(10):FC13–FC15. https://doi.org/10.7860/jcdr/2014/10708.4922 CrossRefPubMedPubMedCentral

Rosen DG, Laucirica R, Verstovsek G (2009) Fine needle aspiration of male breast lesions. Acta Cytol 53(4):369–374. https://doi.org/10.1159/000325335 CrossRefPubMed

Siddiqui MT, Zakowski MF, Ashfaq R, Ali SZ (2002) Breast masses in males: multi-institutional experience on fine-needle aspiration. Diagn Cytopathol 26(2):87–91. https://doi.org/10.1002/dc.10066 CrossRefPubMed

Westenend PJ, Jobse C (2002) Evaluation of fine-needle aspiration cytology of breast masses in males. Cancer 96(2):101–104. https://doi.org/10.1002/cncr.10483 CrossRefPubMed

10.

Bazzocchi M, Vianello E, Linda A, Londero V, Zuiani C (2010) Male breast lesions: which abnormalities really need core needle biopsy? Tumori 96(2):266–270CrossRefPubMed

11.

Bicchierai G, Nori J, Livi L, De Benedetto D, Vanzi E, Boeri C, Bianchi S, Becherini C, Meattini I (2017) Core needle biopsy for the assessment of unilateral male breast lesions. Eur J Surg Oncol 43(4):680–682. https://doi.org/10.1016/j.ejso.2016.07.144 CrossRefPubMed

12.

Janes SE, Lengyel JA, Singh S, Aluwihare N, Isgar B (2006) Needle core biopsy for the assessment of unilateral breast masses in men. Breast 15(2):273–275. https://doi.org/10.1016/j.breast.2005.05.003 CrossRefPubMed

13.

Westenend PJ (2003) Core needle biopsy in male breast lesions. J Clin Pathol 56(11):863–865. https://doi.org/10.1136/jcp.56.11.863 CrossRefPubMedPubMedCentral

14.

Wauters CA, Kooistra BW, de Kievit-van der Heijden BW, Strobbe LJ (2010) Is cytology useful in the diagnostic workup of male breast lesions? A retrospective study over a 16-year period and review of the recent literature. Acta Cytol 54(3):259–264. https://doi.org/10.1159/000325032 CrossRefPubMed

15.

Boerner S, Fornage BD, Singletary E, Sneige N (1999) Ultrasound-guided fine-needle aspiration (FNA) of nonpalpable breast lesions: a review of 1885 FNA cases using the National Cancer Institute-supported recommendations on the uniform approach to breast FNA. Cancer 87(1):19–24. https://doi.org/10.1002/(SICI)1097-0142(19990225)87:1 CrossRefPubMed

16.

Verkooijen HM (2002) Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpable breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 99(6):853–859. https://doi.org/10.1002/ijc.10419 CrossRefPubMed

17.

Jung I, Kim MJ, Moon HJ, Yoon JH, Kim EK (2018) Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience. Ultrasonography 37(1):55–62. https://doi.org/10.14366/usg.17028 CrossRefPubMed

18.

Schueller G, Jaromi S, Ponhold L, Fuchsjaeger M, Memarsadeghi M, Rudas M, Weber M, Liberman L, Helbich TH (2008) US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases. Radiology 248(2):406–413. https://doi.org/10.1148/radiol.2482071994 CrossRefPubMed

Titel: Is core needle biopsy effective at diagnosing male breast lesions?
verfasst von: Yinlong Yang
Shiping Li
Guangyu Liu
Zhiming Shao
Publikationsdatum: 05.06.2019
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 2/2019
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-019-05312-x

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Is core needle biopsy effective at diagnosing male breast lesions?

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer

Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease

Quality of DCIS information on the internet: a content analysis

Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype

Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia

Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie